Lobe Sciences Ltd. Announces That The Drug Enforcement Administration Has Issued The Initial 2023 Quota Allowing Export Of L-130 Pharmaceutical Investing
Promise of BetterLife's Non-hallucinogenic LSD For Treating Mood Disorders Highlighted in Medical Xpress Article Pharmaceutical Investing
BetterLife Files Amended and Restated Offering Document for Offering of Units Pharmaceutical Investing
Seelos Therapeutics Announces Registered Direct Offering of Common Stock and Warrants to Purchase Common Stock Psychedelics Investing
Omineca Announces Upsized and Fully Allocated $2.8 Million Brokered Financing of Flow-Through Units Pharmaceutical Investing
Betterlife Publishes Promising Results from a Study Titled "A Non-Hallucinogenic LSD Analog With Therapeutic Potential For Mood Disorders" Pharmaceutical Investing
